Basic Materials / Specialty ChemicalsIstanbul
$1561.00
-13.00 (-0.83%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $150.8M · quality 44.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$17.2B
P/E
N/A
•EV/EBITDA
30.6x
↑ROE
-33.2%
↓Gross Margin
43.1%
↑Debt/Equity
0.75
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+11.6%
FCF CAGR
-23.0%
FCF margin
3.4%
FCF / Net income
-0.52x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.37B · net income $-291.5M · FCF $150.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.37B | $4.37B | $5.32B | $4.50B | $3.14B |
| Net Income | $-291.5M | $-291.5M | $-318.7M | $-210.2M | $-35.9M |
| EBITDA | $572.0M | $572.0M | $523.5M | $446.4M | $435.9M |
| EPS | -26.51 | -26.51 | -28.99 | -19.28 | -3.59 |
| Gross Margin | 43.1% | 43.1% | 31.9% | 31.6% | 28.5% |
| Operating Margin | 8.7% | 8.7% | 7.5% | 8.2% | 7.7% |
| Net Margin | -6.7% | -6.7% | -6.0% | -4.7% | -1.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.75 | 0.75 | 0.54 | 0.47 | 1.60 |
| Current Ratio | 1.00 | 1.00 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $150.8M | $150.8M | $25.2M | $619.3M | $329.9M |
| Returns | |||||
| ROE | -33.2% | -33.2% | -27.3% | -18.8% | -10.4% |
| Valuation | |||||
| EV/EBITDA | 30.56 | 30.56 | 33.20 | 42.90 | 8.93 |
| P/B | 19.52 | 19.52 | 14.75 | 17.45 | 12.20 |
| Growth & Yield | |||||
| Revenue Growth | -17.7% | -17.7% | 18.3% | 43.0% | — |
| EPS Growth | 8.6% | 8.6% | -50.4% | -437.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+15.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-28.99 → -26.51
Residual
+15.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.